July 25, 2023 07:07 AM EDT
Law

Ab­Cellera hopes to restart patent in­fringe­ment law­suits against Berke­ley Lights af­ter US patent of­fice de­nies re­hear­ing

Katherine Lewin

News Reporter

An­ti­body biotech Ab­Cellera de­clared vic­to­ry on Mon­day in a patent fight with bi­ol­o­gy tools com­pa­ny Berke­ley Lights af­ter a US Patent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

A service from the Financial Times